Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C11H16ClNO2 |
| Molecular Weight | 229.703 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=CC(CC(C)N)=C(OC)C=C1Cl
InChI
InChIKey=ACRITBNCBMTINK-UHFFFAOYSA-N
InChI=1S/C11H16ClNO2/c1-7(13)4-8-5-11(15-3)9(12)6-10(8)14-2/h5-7H,4,13H2,1-3H3
| Molecular Formula | C11H16ClNO2 |
| Molecular Weight | 229.703 |
| Charge | 0 |
| Count |
|
| Stereochemistry | RACEMIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Optical Activity | ( + / - ) |
CNS Activity
Originator
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: P28223 Gene ID: 3356.0 Gene Symbol: HTR2A Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/24142203 |
4.0 nM [Ki] | ||
Target ID: P28335 Gene ID: 3358.0 Gene Symbol: HTR2C Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/24142203 |
3.54 nM [Ki] |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/25217551
A fatal intoxication: dosage range of 1.5–3.0 mg with duration time of 12–24 h. At the highest ingested dose (2.4 mg)
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/24142203
5-HT2A and 5-HT2C receptors HEK cells expressing the human 5-HT2A receptor (HEK-5-HT2A cells) or the human 5-HT2C receptor (HEK-5-HT2C cells) were used. In the 5-HT2A [3H]AA release assay, 2,5-Dimethoxy-4-chloroamphetamine (DOC) and 5-HT were agonists with similar efficacies while potencies differed significantly. DOC were very potent with EC50 values that did not differ from serotonin and LSD. In HEK-h5-HT2C cells, the phenethylamines were tested for their affinities for the [125I]DOI binding site and effects on 5-HT2C-mediated IP-1 turnover. In the [125I]DOI binding assay, there were significant differences in affinities DOC, serotonin and LSD had similar, low nanomolar, affinities.
| Substance Class |
Chemical
Created
by
admin
on
Edited
Tue Apr 01 16:22:36 GMT 2025
by
admin
on
Tue Apr 01 16:22:36 GMT 2025
|
| Record UNII |
8Y1C6K0PCA
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
WIKIPEDIA |
Designer-drugs-2,5-Dimethoxy-4-chloroamphetamine
Created by
admin on Tue Apr 01 16:22:36 GMT 2025 , Edited by admin on Tue Apr 01 16:22:36 GMT 2025
|
||
|
WIKIPEDIA |
PiHKAL
Created by
admin on Tue Apr 01 16:22:36 GMT 2025 , Edited by admin on Tue Apr 01 16:22:36 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
8Y1C6K0PCA
Created by
admin on Tue Apr 01 16:22:36 GMT 2025 , Edited by admin on Tue Apr 01 16:22:36 GMT 2025
|
PRIMARY | |||
|
DTXSID60894189
Created by
admin on Tue Apr 01 16:22:36 GMT 2025 , Edited by admin on Tue Apr 01 16:22:36 GMT 2025
|
PRIMARY | |||
|
123431-31-2
Created by
admin on Tue Apr 01 16:22:36 GMT 2025 , Edited by admin on Tue Apr 01 16:22:36 GMT 2025
|
PRIMARY | |||
|
100000182707
Created by
admin on Tue Apr 01 16:22:36 GMT 2025 , Edited by admin on Tue Apr 01 16:22:36 GMT 2025
|
PRIMARY | |||
|
2,5-DIMETHOXY-4-CHLOROAMPHETAMINE
Created by
admin on Tue Apr 01 16:22:36 GMT 2025 , Edited by admin on Tue Apr 01 16:22:36 GMT 2025
|
PRIMARY | |||
|
542036
Created by
admin on Tue Apr 01 16:22:36 GMT 2025 , Edited by admin on Tue Apr 01 16:22:36 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
SALT/SOLVATE -> PARENT |
|
||
|
|
ENANTIOMER -> RACEMATE |
|
||
|
|
ENANTIOMER -> RACEMATE |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
|